![Hyperpolarized [1-13C] pyruvate MRI for metabolic assessment of prostate cancer osseous metastases following immune therapy.](http://radiology.ucsf.edu/sites/radiology.ucsf.edu/files/wysiwyg/IMAGES-Posts-INSTAGRAM-HMTRC%20blog.jpg "Hyperpolarized [1-13C] pyruvate MRI for metabolic assessment of prostate cancer osseous metastases following immune therapy.")
With funding from the National Institutes for Health, the Hyperpolarized MRI Technology Resource Center (HMTRC) develops and disseminates hyperpolarized (HP) 13C MR techniques and instrumentation, specialized data acquisition methodology and analysis software for biomedical research. Hyperpolarized 13C MRI is an emerging molecular imaging technique that provides unprecedented tissue metabolic information. The overarching goal of the HMTRC is to advance precision molecular imaging and address unmet clinical needs in cancers and various other diseases. Established in 2011, the HMTRC is the quintessential example of our department’s vision of Leading Imaging Innovation to Improve Health, and its strategic pillar of Team Science and Moonshot.
Hyperpolarized 13C MRI – a paradigm-shifting molecular imaging technology
Hyperpolarized 13C MRI is an emerging powerful molecular imaging…
